Mild cognitive impairment definitions: more evolution than revolution

Eugene Yh Tang1, Carol Brayne, Emiliano Albanese

  • 1Institute of Health & Society, Newcastle University, Newcastle upon Tyne, UK.

Insights

Early dementia detection is crucial for prevention. This study examines new criteria for Mild Cognitive Impairment (MCI), exploring their clarity and research implications for identifying individuals at risk.

Area of Science:

  • Neurology
  • Gerontology
  • Psychiatry

Background:

  • Early identification of dementia risk is vital for secondary prevention.
  • Mild Cognitive Impairment (MCI) was proposed to bridge normal aging and dementia.
  • The clinical and research validity of MCI is currently debated.

Purpose of the Study:

  • To evaluate new criteria for Mild Cognitive Impairment (MCI).
  • To discuss the conceptual clarity of proposed MCI definitions.
  • To highlight the implications of these definitions for future research.

Main Methods:

  • Review of proposed diagnostic criteria for MCI.
  • Analysis of criteria from DSM-5, NIA-AA, and International Working Group.
  • Discussion of conceptual frameworks and research utility.

Main Results:

  • Multiple new criteria for MCI have been proposed.
  • These criteria include mild neurocognitive disorder (DSM-5).
  • The clarity and utility of these evolving definitions require further examination.

Conclusions:

  • New MCI criteria aim to refine the identification of individuals at risk for dementia.
  • Further research is needed to validate these definitions and their clinical implications.
  • Clarifying MCI conceptualization is essential for advancing dementia research and prevention.

Related Concept Videos

Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
1.1K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.3K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
730
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
914
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Amnesia01:13

Amnesia

Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
883